Use of a probioitic to decrease enteric hyperoxaluria

Kidney International

Volumn 68, Issue 3, 2005, Pages 1244-1249

  Lieske, John C ^a   Goldfarb, David S ^b   De Simone, Claudio ^b   Regnier, Cynthia ^b  

^a MAYO CLINIC   (United States)

^b NONE

Author keywords

Calcium oxalate; Fat malabsorption; Lactobacilli; Nephrolithiasis

Indexed keywords

CALCIUM OXALATE; FAT; OXADROP; PROBIOTIC AGENT; OXALIC ACID DERIVATIVE;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ARTICLE; CALCIUM OXALATE STONE; CELIAC DISEASE; CHRONIC PANCREATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; GASTRECTOMY; HUMAN; HYPEROXALURIA; LACTIC ACID BACTERIUM; MALABSORPTION; MALE; OBESITY; POSTGASTRECTOMY SYNDROME; PRIORITY JOURNAL; REMISSION; ROUX Y ANASTOMOSIS; STATISTICAL SIGNIFICANCE; STOMACH BYPASS; ULCERATIVE COLITIS; URINALYSIS; URINARY EXCRETION; BIFIDOBACTERIUM; CLINICAL TRIAL; INTESTINE; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS BREVIS; MICROBIOLOGY; MIDDLE AGED; NEPHROLITHIASIS; STREPTOCOCCUS THERMOPHILUS; TREATMENT OUTCOME; URINE;

AGED; BIFIDOBACTERIUM; HUMANS; HYPEROXALURIA; INTESTINES; KIDNEY CALCULI; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS BREVIS; MALABSORPTION SYNDROMES; MALE; MIDDLE AGED; OXALATES; PROBIOTICS; STREPTOCOCCUS THERMOPHILUS; TREATMENT OUTCOME;

EID: 32644485841     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2005.00520.x     Document Type: Article

References (32)

1. PARDI DS, TREMAINE WJ, SANDBORN WJ, MCCARTHY JT: Renal and urological complications of inflammatory bowel disease. Am J Gastroenterol 93:500-514, 1998
2. HYLANDER E, JARNUM S, NIELSEN K: Calcium treatment of enteric hyperoxaluria after jejunoileal bypass for morbid obesity. Scand J Gastroent 15:349-352, 1980
3. CANOS HJ, HOGG GA, JEFFERY JR: Oxalate nephropathy due to gastrointestinal disorders. Can Med Assoc J 124:729-733, 1981
4. DRENICK EJ, STANLEY TM, BORDER WA, et al: Renal damage with intestinal bypass. Ann Intern Med 89:594-599, 1978
5. MODIGLIANI R, LABAYLE D, AYMES C, DENVIL R: Evidence for excessive absorption of oxalate by the colon in enteric hyperoxaluria. Scand J Gastroent 13:187-192, 1978
6. MCLEOD RS, CHURCHILL DN: Urolithiasis complicating inflammatory bowel disease. J Urol 148:974-978, 1992
7. STAUFFER JQ: Hyperoxaluria and intestinal disease. The role of steatorrhea and dietary calcium in regulating intestinal oxalate absorption. Am J Dig Dis 22:921-928, 1977
8. ANDERSSON H, BOSAEUS I: Hyperoxaluria in malabsorptive states. Urol Int 36:1-9, 1981
9. PARIVAR F, LOW RK, STOLLER ML: The influence of diet on urinary stone disease. J Urol 155:432-440, 1996
10. ARGENZIO RA, LIACOS JA, ALLISON MJ: Intestinal oxalate-degrading bacteria reduce oxalate absorption and toxicity in guinea pigs. J Nutr 118:787-792, 1988
11. CAMPIERI C, CAMPIERI M, BERTUZZI V, et al: Reduction of oxaluria after an oral course of lactic acid bacteria at high concentration. Kidney Int 60:1097-1105, 2001
12. GIONCHETTI P, RIZZELLO F, VENTURI A, et al: Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: A double-blind, placebo-controlled trial. Gastroenterology 119:305-309, 2000
13. SALMINEN S, VON WRIGHT A, MORELLI L, et al: Demonstration of safety of probiotics - A review. Int J Food Microbiol 44:93-106, 1998
14. KUNZ A, FARICHOK MP: Two cases of Lactobacillus bacteremia during probiotic treatment of short gut syndrome. J Pediatr Gastroenterol Nutr 39:437, 2004
15. WERNESS PJ, BROWN CM, SMITH LH, FINLAYSON B: EQUIL2: A BASIC computer program for the calculation of urinary saturation. J Urol 134:1242-1244, 1985
16. ROBERTSON WG, HUGHES H: Importance of mild hyperoxaluria in the pathogenesis of urolithiasis - New evidence from studies in the Arabian peninsula. Scanning Microsc 7:391-401, 1993
17. PAK CY, ADAMS-HUET B, POINDEXTER JR, et al: Relative effect of urinary calcium and oxalate on saturation of calcium oxalate. Kidney Int 66:2032-2037, 2004
18. ROBERTSON WG, PEACOCK M, NORDIN BEC: Activity products in stone-forming and non-stone-forming urine. Clin Sci 34:579-594, 1968
19. NEMEH MN, WEINMAN EJ, KAYNE LH, LEE DB: Absorption and excretion of urate, oxalate, and amino acids, in Kidney Stones: Medical and Surgical Management, edited byCoe FC, Favus MJ, Pak CYC, Parks JH, Preminger GM, Philadelphia, Lippincott-Raven, 1996, pp 303-322
20. WILLIAMS A, WILSON DM: Dietary intake, absorption, metabolism, and excretion of oxalate. Semin Nephrol 10:2-8, 1990
21. KRISHNAMURTHY MA, HRUSKA KA, CHANDHOKE PS: The urianry response to an oral load in recurrent calcium oxalate stone formers. J Urol 169:2030-2033, 2003
22. 2] oxalate. J Am Soc Nephrol 10:S329-S333, 1999
23. MARANGELLA M, FRUTERO B, BRUNO M, LINARI F: Hyperoxaluria in idiopathic calcium stone disease: Further evidence of intestinal hyperabsorption of oxalate. Clin Sci 63:381-385, 1982
24. LINDSJO M, BO G, FELLSTROM B, LJUNGHALL S: Intestinal oxalate and calcium absorption in recurrent renal stone formers and healthy subjects. Scan J Urol Nephrol 23:55-59, 1989
25. SCHWILLE PO, HANISCH E, SCHOLZ D: Postprandial hyperoxaluria and intestinal oxalate absorption in idiopathic renal stone disease. J Urol 132:650-655, 1984
26. HATCH M, FREEL RW, VAZIRI ND: Regulatory aspects of oxalate secretion in enteric oxalate elimination. J Am Soc Nephrol 10:S324-S328, 1999
27. HATCH M, FREEL RW, VAZIRI ND: Intestinal excretion of oxalate in chronic renal failure. J Am Soc Nephrol 5:1339-1343, 1994
28. SIDHU H, ALLISON M, PECK AB: Identification and classification of Oxalobacter formigenes strains by using oligonucleotide probes and primers. J Clin Microbiol 35:350-353, 1997
29. SIENER R, EBERT D, HESSE A: Urinary oxalate excretion in female calcium oxalate stone formers with and without a history of recurrent urinary tract infections. Urol Res 29:245-248, 2001
30. SIDHU H, SCHMIDT ME, CORNELIUS JG, et al: Direct correlation between hyperoxaluria/oxalate stone disease and the absence of the gastrointestinal tract-dwelling bacterium Oxalobacter formigenes: Possible prevention by gut recolonization or enzyme replacement therapy. J Am Soc Nephrol 10:S334-S340, 1999
31. CANNON JP, LEE TA, BOLANOS JT, DANZIGER LH: Pathogenic relevance of Lactobacillus: A retrospective review of over 200 cases. Eur J Clin Microbiol Infect Dis 24:31-10, 2005
32. GUARINO A, CANANI RB, SPAGNUOLO MI, et al: Oral bacterial therapy reduces the duration of symptoms and of viral excretion in children with mild diarrhea. J Ped Gastroenterol Nutr 25:516-519, 1997